Related by context. All words. (Click for frequent words.) 85 submitted Marketing Authorization 79 Files IND 76 Submits Supplemental 76 Application BLA 74 Application MAA 74 submit Biologics License 74 submitted Marketing Authorisation 73 Submits Biologics License Application 73 Receives Orphan Drug Designation 72 Submits IND 72 FDA Accepts 71 Completes Patient Enrollment 71 Submits NDA 71 Therapeutic Competitors Companies 71 Initiates Enrollment 71 Receives Approvable Letter 71 Announce License Agreement 70 Begins Dosing 70 Nasdaq XTLB 70 Initiates Phase II 70 highly purified pasteurized 69 Initiates Phase III 69 Nasdaq TARG 69 Files Investigational 69 Receives Complete Response 69 Submits Response 69 Announces Tentative Approval 69 Receives Fast Track 68 please visit http:/www.vandapharma.com 68 Receives Milestone Payment 68 Presents Positive 68 Receives Tentative Approval 68 Granted Orphan Drug 68 BioSante Pharmaceuticals Announces 68 Initiates Dosing 68 Nasdaq AVNC 68 Receives Orphan Drug 68 Initiates Clinical Trial 68 Mylan Receives Approval 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 Nasdaq MNKD focuses 67 Initiates Clinical 67 IG HCR ;) CO 67 submitted supplemental Biologics 67 Nasdaq PGNX 67 NASDAQ CRXL 67 Inc. www.micromet inc.com 67 Presents Positive Preclinical 67 Targanta Therapeutics Corporation 67 Nasdaq HALO 67 Announce Licensing Agreement 67 assigned PDUFA 67 Presents Preclinical Data 67 Receive Milestone Payment 67 Namenda Memantine HCl 67 Nasdaq IDIX 67 Crucell NV Euronext 67 Inc. Nasdaq OXGN 67 PRNewswire FirstCall Labopharm 67 Receives Tentative FDA 66 Taro Receives 66 Completes Enrollment 66 StaphVAX R 66 Vaccine Adjuvant 66 Receives Patent 66 JOULFERON 66 NASDAQ MNKD focuses 66 Licenses Novel 66 liver resection surgeries 66 Nasdaq DVAX 66 Receives CE Marking 66 rolling Biologics License 66 Vitrasert R 66 nanofiltered plasma derived 66 JAK2 Inhibitor 66 visit http:/www.mannkindcorp.com 66 ALLSCHWIL BASEL SWITZERLAND 66 Receives NASDAQ 66 Fast Track Status 66 Inc Therapeutic Competitors 66 Gets FDA Clearance 66 initiated Phase Ib 66 Act PDUFA date 66 SIX RO ROG 65 Marketing Approval PMA 65 License Application sBLA 65 LSE SHP.L 65 Receives Positive Opinion 65 pralatrexate injection folate analogue 65 By JAMAAL ABDUL 65 Combination REOLYSIN R 65 Nasdaq EPCT 65 methylnaltrexone bromide 65 OTCBB CAEH 65 Crofelemer budesonide foam 65 PROVENGE ® 65 Patent Issued 65 Nasdaq IMGN 65 Inc. Nasdaq IMGN 65 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 65 OTCBB FCSC 65 Supplemental Biologics License Application 65 Psoriasis Drug 65 Roche OTC RHHBY 65 developing Zerenex ferric 65 Crucell NV NYSE Euronext 65 FDA Clears 65 expanded autologous cellular 65 Develop Novel 65 NASDAQ XTLB 65 Intravenous Human 65 NASDAQ ISTA 65 iloprost Inhalation Solution 65 Nasdaq CRXL 65 Hsp# Inhibitor 65 Nasdaq PPHM clinical 65 See BioWorld Today 65 PRN FDA Approves 65 NASDAQ AVNR 65 Inc. Nasdaq IDMI 65 TRACON Pharmaceuticals 65 supplemental biologics 65 Staphylococcus aureus Immune Globulin 65 RANK Ligand inhibitor 65 Corp. Nasdaq BSTC 64 Initiates Clinical Trials 64 TSX VENTURE SLX OTCBB 64 Inc. NASDAQ SIRT 64 Bradmer Pharmaceuticals 64 Submits Investigational 64 platform HDL Mimetic 64 Transdermal Drug 64 Nasdaq VNDA 64 Issued Patent 64 ZALBIN 64 Delaying apoptosis may 64 nasal calcitonin product 64 Initiates Phase 64 markets HP Acthar 64 TM Aganocide 64 Ready Templates 64 NASDAQ PGNX 64 RNAi Therapeutic 64 Meets Primary Endpoint 64 AN# topical anti 64 Present Preclinical Data 64 Sign Licensing Agreement 64 Begins Shipment 64 Reveals Positive 64 ONCY 64 Enteral Feed Devices 64 Files Patent 64 OTCBB IMUC 64 GTC recombinant form 64 DNA methyltransferase inhibitors 64 mesylate tablets approved 64 Jumps Higher 64 Initiate Phase 64 CIMZIA r 64 Files Patent Application 64 Oral Calcitonin 64 Inc. Nasdaq CRTX 64 Inc. Nasdaq SEPR 64 Inc. Amex PRW 64 Oracea TM 64 Presents Preclinical 64 Inc. Nasdaq MITI 64 Submits Application 64 Nicotine Conjugate Vaccine 64 OTCBB NVDL 64 Drug Candidate 64 BOTHELL Wash. Business Wire 64 OTCBB JMAR leading 64 Receives Clearance 64 Announce Initiation 64 Company Nasdaq PRGO 64 Genentech sanofi aventis 64 Demonstrates Significant 64 5 lipoxygenase activating 64 NASDAQ MIPI 64 Completes Dosing 64 Announces Licensing Agreement 64 OTCBB INSV 64 Grants Orphan Drug 63 NASDAQ RNAI 63 Nasdaq AEGR 63 Ohr Pharmaceutical Inc. 63 Investigational Compound 63 Inc. NASDAQ HITK 63 Taglich Brothers Initiates Coverage 63 Euronext Paris Code Isin 63 Canaccord Genuity Maintains Hold 63 Nasdaq CLDX 63 Risperidone Oral Solution 63 Horizant ™ 63 molecular therapeutics immunotherapies 63 VIVITROL ® 63 Files Provisional 63 Receives Notice Related 63 Nasdaq NOVN 63 Resubmits 63 Nasdaq SPPI 63 Launches Generic Version 63 NASDAQ BDSI 63 Announce Collaboration Agreement 63 MONSTERSTOX.COM Monsterstox.com 63 PharmaVitae Profile 63 OTCBB HXBM developer 63 include Altastaph TM 63 Reports Preclinical Data 63 Announces Poster Presentations 63 ANDA Filing 63 NasdaqGM NTEC today 63 Report companiesandmarkets.com adds 63 Generic Version 63 Therapeutic Competitors 63 Extends Collaboration 63 gastrointestinal disorders characterized 63 AMEX KAL 63 R MSCRAMM 63 Initiate Clinical Trial 63 cleared IND Investigational 63 PROLOR Biotech Inc. 63 LYON France BUSINESS WIRE 63 Telik logo TELINTRA 63 TRANSDUR ® 63 commercializing oxidized glutathione 63 Nasdaq CADX 63 Nasdaq VRTX 63 Investigational Oral 63 Inc. Nasdaq SUPG 63 Completes Patient Enrolment 63 Patient Enrollment 63 Arthritis Drug 63 Nasdaq PGNX today 63 Nasdaq GNTA 63 Enrolls First 63 OTCBB FCSC biotechnology 63 TELINTRA R 63 Desktop TEMP UPDATE idx 63 NASDAQ ROSG leading 63 Announces License Agreement 63 candidate REP# 63 VentiRx Pharmaceuticals 63 include Phenoptin TM 63 FDA APPROVES 63 Expanded Indication 63 BioGlue R 63 NASDAQ GTCB 63 Licenses Patents 63 PDUFA Date 63 Emergent marketed 63 testosterone gel LibiGel 63 Lenocta TM 63 OTCBB CLRI 63 SPL# Gel vaginal microbicide 63 Announces FDA Clearance 62 vapreotide acetate 62 Infectious Disease Testing 62 Nasdaq THLD 62 PRAECIS PHARMACEUTICALS INCORPORATED 62 ferumoxytol Injection 62 NASDAQ ENMD 62 hyaluronidase enzyme 62 dihydrochloride Phase 3 62 Inc. OTCBB ALRX 62 Inc. Nasdaq AMGN 62 Receives FDA Clearance 62 ABL inhibitor 62 Therapeutic Competitors Report 62 Fortical ® 62 Pruvel TM 62 delivers fluocinolone acetonide FA 62 sarcoma melanoma 62 please visit www.dyax.com 62 BIOTECHNOLOGY SOURCE 62 Luveris R Ovidrel R 62 pentadentate logo R 62 Aztreonam Lysine 62 Nasdaq QLTI 62 Inc. Nasdaq AVRX 62 anti botulism antibody 62 Pivotal Phase III 62 Bullish Average Crossover 62 Personalized Immunotherapy 62 CAMPATH R 62 Receives SFDA Approval 62 Inc. NASDAQ OXGN 62 Successfully Completes Phase 62 Romiplostim 62 NASDAQ IDEV 62 NYSE Amex RGN 62 SABER ™ 62 Nasdaq HALO biopharmaceutical 62 Nasdaq IDRA 62 LSE SHP NASDAQ SHPGY 62 Biologic License Application BLA 62 Molecular Diagnostic Test 62 NASDAQ ADLR 62 molecular imaging radiopharmaceutical 62 Commences Phase 62 Recombinant Human 62 PAION AG ISIN 62 Advancis Pharmaceutical Corporation 62 dependent kinase inhibitor 62 NASDAQ SHPGY 62 KRYSTEXXA TM pegloticase 62 GTC NASDAQ GTCB 62 non nucleoside inhibitor 62 developing ACAPODENE 62 IND Application 62 Cypress Bioscience Inc 62 supplemental Biologics License Application 62 topical gel formulation 62 Surgical Adhesive 62 Nasdaq SOMX specialty 62 Welcomes Analyst Initiation 62 Antibody Drug Conjugate 62 Nasdaq MICU 62 sapropterin dihydrochloride 62 Regains NASDAQ 62 Begins Clinical Trial 62 Barrier Therapeutics Inc. 62 Phase 2a Trial 62 NEXM 62 Generic Versions 62 Receives Favorable 62 Nasdaq KERX 62 ASX PGL 62 IND Filing 62 OTC BB PVCT 62 OctoPlus licensed 62 Rheumatoid Arthritis Drug 62 Inc. Amex PIP 62 Inc. NASDAQ SGEN 62 NASDAQ PPHM clinical 62 Positive Opinion 62 Omigard TM 62 NASDAQ CGEN announced 62 Novel Oral 62 R roscovitine CDK cyclin 62 Genta Incorporated OTCBB GNTA 62 AMEX RGN 62 visit www.noven.com 62 Nasdaq CYCC 62 Kosan Biosciences Incorporated 62 PRNewswire FirstCall BioSpecifics Technologies 62 Orphan Drug designations 62 pharmacogenomic translational research 62 PSDV 62 MSCRAMM ® 62 Drug Fails 62 Nasdaq VRTX today 62 Trelstar R 62 DRRX 62 Amira Pharmaceuticals 62 Clinical Trial Results 62 Bullish Technical Alert 62 topical antifungal product 62 Teva Provides Update 62 Nasdaq ACEL 62 PRNewswire FirstCall Vanda Pharmaceuticals 62 TSX SHQ 62 Nasdaq AUXL 62 CRXL 62 Tezampanel 62 OTCBB ILNS 62 approved incretin mimetic 62 PRNewswire FirstCall Micromet 62 targeted anticancer biopharmaceuticals 62 please visit www.eisai.com 62 using VIAdel TM 62 Nasdaq MNKD focused 62 Impax ANDA 62 Patent Covering 62 Voluntarily Withdraws 62 Metformin HCl 62 Nasdaq AMAG 62 Sinks Lower 62 HAYWARD Calif. BUSINESS WIRE 62 FOLOTYN ® 62 Nasdaq ENCY 62 Announces Initiation 62 Sign License Agreement 62 Phase IIb Trial 62 NASDAQ CRTX 62 Strengthens Position 62 Inc. AMEX YMI 62 Earns Milestone Payment 61 Nasdaq SGEN 61 Novartis VIRT X 61 GLOBE NEWSWIRE Cytomedix 61 Prolongs Survival 61 novel emulsion formulation 61 Aloprim TM allopurinol sodium 61 Nasdaq PHRM 61 FDA Approvable Letter 61 Qutenza TM 61 sitaxsentan sodium 61 TNF Blockers 61 Terminate Merger Agreement 61 Taiho Pharmaceutical 61 Orphan Status 61 BYETTA ® 61 Shows Promising 61 Civacir 61 novel proprietary KL4 61 #/#/# DIAGNOS inc 61 TSX BSY 61 PNP inhibitor 61 ALAMEDA Calif. BUSINESS WIRE 61 Nasdaq ENMD 61 mesylate tablets 61 Nasdaq SLXP 61 Inc. NASDAQ MEDX 61 Restructures Operations 61 Patent Broadly Covering 61 TSRX 61 REAs Rich Enterprise 61 Xcytrin R 61 Silenor ® doxepin 61 Settles Patent Litigation 61 Inc. NASDAQ NOVC 61 Fast Track designations 61 OTCBB TDLP 61 NYSE Amex YMI 61 Peginterferon alfa 2b 61 4SC AG ISIN DE# 61 Veronate R 61 OTCBB DORB DOR 61 Voluntarily Withdraw 61 OTCQX QRXPY 61 Nasdaq PARD 61 NASDAQ ARRY 61 equine osteoarthritis marketed 61 refractory chronic lymphocytic 61 Xyzal R 61 Nasdaq MYRX 61 Settle Patent Litigation 61 PRNewswire FirstCall Peregrine Pharmaceuticals 61 Inc. NASDAQ HEPH 61 neuromodulation therapy 61 Receives Marketing Authorization 61 NDA Submission 61 Patient Enrolment 61 NASDAQ AVEO biopharmaceutical 61 CysDisplay R 61 AMEX PLX 61 Enhances User Experience 61 Nasdaq ENZN 61 COMUNICADO DE 61 corticotropin injection 61 Awarded Patents 61 developing adecatumumab 61 R sorafenib tablets 61 Panflu TM Sinovac 61 Idera Pharmaceuticals 61 DRUG ADMINISTRATION 61 Initiates Phase 2b 61 High Growth Forecasted 61 Settle Patent Dispute 61 Insmed Incorporated NASDAQ INSM 61 PRNewswire FirstCall Indevus Pharmaceuticals 61 UGNE 61 Develop Next Generation 61 NASDAQ IMCL global 61 XGEVA ™ 61 SNPY 61 novel histone deacetylase 61 Nabi HB R 61 Nasdaq ABRX 61 depressive episodes associated 61 candidates Azedra TM 61 Nasdaq TGAL leading 61 ELADUR ™ 61 LymphoStat B TM 61 Tibotec Therapeutics division 61 Regains Full 61 NASDAQ CORT 61 Announces Immediate Availability 61 Theratechnologies submitted 61 Antigenics NASDAQ AGEN 61 Nasdaq SIGA 61 OTCBB GNTA 61 Schizophrenia Drug 61 rHuPH# recombinant human 61 Solutions CVAS 61 Release Capsules 61 Collaborators Publish 61 Mg Usa 61 Phase 2b Clinical Trial 61 Nasdaq AVII 61 Connetics Corporation 61 Announce Merger Agreement 61 Signs License Agreement 61 Phase IIb Clinical Trial 61 NASDAQ MNTA 61 Inc. NASDAQ CVTX 61 novel synthetic PEGylated 61 NicVAX TM 61 OTCBB IBPM 61 OTCBB ADXS 61 TRANSDUR ™ 61 Monoclonal Antibody 61 Kinase Inhibitor 61 IMPACS R 61 PRNewswire FirstCall EntreMed 61 Nasdaq MITI biopharmaceutical 61 Q4 Profit Decreases 61 novel orally inhaled 61 FACTIVE R gemifloxacin 61 NYSE Amex PTN 61 VISICOL R 61 Amex KAL 61 NASDAQ CGPI 61 lead molecular radiotherapeutic 61 Orphan Drug designation 61 ® NasdaqCM RPRX 61 programs visit http:/www.bionovo.com 61 MIND CTI LTD 61 NeutroPhase TM 61 Files Shelf Registration Statement 61 NASDAQ SOMX specialty 61 NASDAQ IMMU 61 inflammatory PDE 61 Inc. Nasdaq CVTX 61 OTCBB JMAR 61 commercialize oritavancin 61 Flagship Product 61 GLOBE NEWSWIRE OXiGENE 60 Thrombin topical Recombinant 60 Q2 Loss Narrows 60 proprietary intravenous formulation 60 Marketing Authorisation 60 Phase 1b Clinical Trial 60 passive immunotherapy products 60 Prodarsan R 60 Novel Antibiotic 60 NASDAQ PCYC 60 NYSE MRX 60 markets Testim ® 60 Single Dose 60 Nasdaq MBRX 60 ICON plc NASDAQ ICLR 60 Migraine Drug 60 male hypogonadism PRO 60 CAMARILLO Calif. Business Wire 60 granted Ortec 60 Achieves Milestone 60 Wins Patent Infringement 60 Inc. NASDAQ VSGN 60 Biologic License Application 60 MedWatch website 60 includes Dideco CarboMedics 60 Nasdaq MOGN 60 PRN4 60 Epilepsy Drug 60 Commence Phase 60 Awarded Qualifying Therapeutic 60 5 lipoxygenase inhibitor 60 Raptiva R 60 Patents Upheld 60 CERVARIX R 60 NASDAQ CPHD 60 Achieves Primary Endpoint 60 TSX VENTURE BIP 60 LightTouch TM 60 Transcept Pharmaceuticals 60 EPIX Pharmaceuticals Inc. 60 AAG geldanamycin analog 60 Phase III Clinical Trial 60 Marketing Authorisation Application 60 Hold Fourth Quarter 60 Inc. Nasdaq CYCC 60 Resubmission 60 Lung Cancer Drug 60 non porcine pancreatic 60 Hedgehog Pathway Inhibitor 60 NASDAQ SCLN 60 Osteoporosis Drug 60 SinuNase ™ 60 oral dihydropyrimidine dehydrogenase DPD 60 OTC ZEGERID 60 Staphylococcus aureus Polysaccharide Conjugate 60 developing Bicifadine serotonin 60 Milestone Payments 60 Generic Version Of 60 Inc. NASDAQ XNPT 60 peptidic compound 60 Protects Against 60 Unsolicited Proposal From 60 HCV RNA polymerase 60 product candidate Lpathomab 60 NEBIDO R 60 Advanced Melanoma 60 NEUPOGEN R 60 candidates Azedra 60 successfully commercialize Iluvien 60 NASDAQ LDIS 60 Confirms Validity 60 Xoma Ltd 60 Femring ® 60 motexafin gadolinium Injection 60 Syntonix Pharmaceuticals 60 researches develops licenses 60 Recommends Approval 60 Study Evaluating 60 Receives Anticipated 60 candidate Hematide TM 60 NYSE Amex AEN 60 NASDAQ SIGA 60 Hematological Malignancies 60 Q2 Loss Widens 60 Dexilant 60 NASDAQ ENZN 60 DARA logo 60 k Premarket Notification 60 Clinical Trials Update 60 Provectus Pharmaceuticals specializes 60 MBRX 60 Markettelegraph.com 60 Revises FY# Outlook 60 OMRIX Biopharmaceuticals Inc. 60 VEGFR2 inhibitor 60 Drug Shows Promise 60 Debuts Next Generation 60 RDYN 60 Frankfurt XMP 60 Launches Next Generation 60 OTCBB DORB 60 Nabi HB Intravenous 60 Kristalose ® lactulose 60 SPRYCEL ® 60 Civacir TM Hepatitis C 60 Acetavance TM 60 Achieves Common Criteria 60 REPRONEX R menotropins 60 agonistic human 60 Alnylam Nasdaq ALNY 60 albiglutide 60 Nasdaq OMER 60 Receives Approval From 60 SYCREST 60 Vicriviroc 60 BNVID 60 novel trazodone formulation 60 Dealmaking Profile 60 KINDERHOOK NY BUSINESS WIRE 60 CTRX 60 Updates Guidance 60 Dynepo TM 60 ENSL 60 OTCBB NPHC 60 Bearish Speculation 60 Calls Purchased 60 Iluvien ® 60 NASDAQ HALO 60 Aldara ® 60 www.pharsight.com 60 R lenalidomide 60 diagnostic molecular imaging 60 Inc. Nasdaq VVUS 60 Oral Spray 60 Nasdaq ICOS 60 ATRA IV 60 Tibotec Pharmaceuticals Ltd. 60 NASDAQ LGND 60 Inc. Nasdaq RDEA 60 MORRISVILLE NC BUSINESS WIRE 60 Awarded Patent 60 mitogen activated ERK kinase 60 Amex PTN 60 REGENERX BIOPHARMACEUTICALS INC. 60 Amex NVD 60 Aztreonam lysine 60 TapImmune Inc. 60 topical non steroidal 60 otcstockexchange.com 60 Amex ANX 60 Nasdaq OSCI 60 visit smith.com 60 PRNewswire FirstCall CEVA 60 GLOBE NEWSWIRE Infinity 60 POSIDUR TM ELADUR TM 60 Aloxi ® 60 Feraheme ® 60 Seasonal Influenza Vaccine 60 CEPHALON 60 Settles Patent Dispute 60 NGSX 60 Prostate Cancer Vaccine 60 Friedreich Ataxia FRDA 60 oncolytic virus therapies 60 GNLB 60 About TenFold TenFold 60 LymphoStat B belimumab 60 selective A2A adenosine receptor 60 Idenix Novartis 60 Nasdaq PPHM 60 investigational oral hepatitis C 60 NASDAQ ALNY 60 PF # [002] 60 Enters Into Collaboration 60 Indevus Pharma 60 OTC Zegerid 60 Receives Conditional 60 Inc. NASDAQ MRNA 60 Bazedoxifene 60 Silodosin 60 Bullish Speculation 60 supplemental Biologics License 60 sNDAs 60 Preclinical Data 60 recombinant biopharmaceutical 60 Liprotamase 60 Gets Bearish Confirmation 60 eHydrogen Solutions eHs specializes 60 Breakthroughstocks.net EXPLOSIVE news 60 FLEXIBLE SOLUTIONS INTERNATIONAL INC. 60 CryptoLogic Limited TSX CRY 60 AzaSite ISV 60 NASDAQ EPIX 60 • deller@dmreg.com • 60 Inc. OTCBB VYTR 60 Complicated Skin 60 prostate secretory 59 Data Avira AntiVir 59 Milestone Payment 59 Provides Shareholder 59 Nasdaq CYCC Nasdaq CYCCP 59 Announces Favorable 59 Surfactant Technology 59 Xolegel 59 visit www.celiocorp.com 59 NASDAQ KERX 59 Inc. NASDAQ ZLCS 59 Japanese Encephalitis Vaccine 59 SpeBio joint venture 59 NasdaqGM SPPI 59 candidate deforolimus 59 Vitamin D analogue 59 systemic lupus erythematosus rheumatoid 59 SWOT Analysis Aarkstore Enterprise 59 Marketing Authorization Application MAA 59 ENLIGHT 59 PI3K/Akt pathway inhibitor 59 acetonide FA 59 memantine HCl 59 Nasdaq SCLN 59 Hematide ™ peginesatide 59 OTCBB HNAB 59 CNW YM BioSciences 59 NASDAQ TARG 59 nano particle tumor suppressor 59 dasatinib Sprycel ® 59 WeissComm Partners +#-#-#-# 59 Announce Licensing 59 Expand Collaboration 59 sapropterin dihydrochloride Phase 59 Nasdaq OSIP 59 Cholesterol Lowering Drug 59 Evoltra ® 59 Nasdaq BMRN 59 Shrink OTCBB INKN 59 OTCBB QTXB 59 Amigal TM 59 ARCALYST ® rilonacept Injection 59 TAXUS Element Stent System 59 AllPennyStocks.com Spotlights 59 Unveils Latest Version 59 PROGENSA R 59 brand ciclesonide HFA 59 Rectangular Column 59 negative allosteric modulator 59 ENL recurrence 59 Nasdaq CYTX 59 Cardiovascular Prosthetic Devices 59 Serostim ® 59 NYSE Amex RNN 59 SCSI Optical Transport 59 Nasdaq IDEV 59 Phase III Pivotal 59 ROSG 59 WOBURN Mass. Business Wire 59 SWX BSLN 59 XL# anticancer compounds 59 STELARA TM 59 PRNewswire FirstCall Genta Incorporated 59 Accelerating apoptosis may 59 Nasdaq CTIC 59 MARLBOROUGH Mass. BUSINESS WIRE 59 OMNARIS HFA 59 NASDAQ CEVA 59 Inc. NASDAQ MITI 59 Kuvan R 59 Signs Merger Agreement 59 Solzira TM 59 PENNSAUKEN NJ BUSINESS WIRE 59 Reaffirms FY# Outlook 59 Significantly Reduces 59 Ltd Therapeutic Competitors 59 HuCAL GOLD R 59 Mg Uk 59 KV.A 59 active AKT inhibitor 59 Sumatriptan Succinate 59 FDA Approvals 59 Corixa Corporation 59 IMPAX Laboratories Inc. 59 RNAi Therapeutics 59 GATTEX TM 59 NASDAQ ALXA 59 Fibrocell Science Inc. 59 Therapeutic Vaccine 59 called Microstructure Chromatograph 59 NYSE Amex GTF 59 NASDAQ INSM 59 Demonstrates Sustained 59 Shows Promise 59 lintuzumab SGN 59 Belimumab 59 Nasdaq VICL 59 Levoleucovorin 59 candidate brentuximab vedotin 59 Stockholders Approve Acquisition 59 Enters Into Licensing Agreement 59 miconazole Lauriad R 59 Nasdaq ALXA announced 59 Reports Receipt 59 dorzolamide hydrochloride 59 vinorelbine emulsion 59 Marketing Authorisation Holder 59 Myrexis Inc. 59 virus HCV protease inhibitor 59 Phase 2b Trial 59 Vidaza R 59 NASDAQ IMCL 59 Vaccine Candidate 59 Nasdaq SMTS develops manufactures 59 OTCBB NVLT biopharmaceutical 59 Options Trader Alert 59 humanized therapeutic 59 Gel repository corticotropin injection 59 HEPH 59 Catalyst Biosciences 59 NeoRx Corporation 59 Albugon 59 Expands Portfolio 59 PRN2 59 Biological License Application 59 AMEX ISV 59 R bendamustine hydrochloride 59 Redhotpennystock.com Alert 59 NASDAQ DVAX 59 NASDAQ INGN 59 include Alferon N 59 Upcoming Deadline 59 ATryn ® GTC recombinant 59 Inc. NASDAQ AVII 59 Panzem R 59 FREMONT CA #/#/# 59 PRNewswire FirstCall Northwest Biotherapeutics 59 Pegloticase 59 NeurogesX Nasdaq NGSX 59 SHP.L 59 dedicated CHAT ROOM 59 OMP designation 59 Biomagnetics Diagnostics Corporation 59 Cholesterol Drug 59 Inc. NASDAQ BPAX 59 Inc. NASDAQ SUPG 59 AMEX RGN www.regenerx.com 59 forodesine purine nucleoside phosphorylase 59 OTCBB INKN 59 Alfacell proprietary ribonuclease 59 R rilonacept Injection 59 AMEX ONI 59 candidate AQ4N 59 AMEX ANX 59 Receives Deficiency Letter 59 Explores Strategic Alternatives 59 selective estrogen receptor modulator 59 PHARMACEUTICALS INC. 59 Signs Licensing Agreement 59 Pain Neutralizer holds 59 Tracleer ® bosentan 59 Pharmos Corporation 59 FDA Orphan Drug 59 www.sanofi aventis.us 59 candidate MyVax 59 cutaneous T 59 Somatuline Depot 59 Delivers Next Generation 59 Modrenal R 59 Nasdaq TGAL 59 NASDAQ INFI 59 use transdermal sumatriptan 59 Adjunctive Therapy 59 OMAPRO ™ 59 platinum chemotherapeutic 59 Manja Bouman CEO 59 IMiDs ® 59 Nasdaq NABI 59 MCSP respectively 59 folate analogue metabolic 59 Releases Next Generation 59 Syndrome LEMS 59 BROOKS AUTOMATION 59 Orphan Designation 59 Xanthus Pharmaceuticals Inc. 59 Pink Sheets ZIPZ 59 Extends Expiration Date 59 Introduces Breakthrough 59 Dendritic Nanotechnologies Inc. 59 Extends Leadership 59 PHRM 59 ORBOTECH LTD 59 Nasdaq CAMT 59 investigational pan BCR 59 markets Gelclair R 59 YM AIM YMBA 59 Orapred ODT 59 Keppra ® XR 59 • nkausar@thespectrum.com • 59 Aethlon Medical Releases 59 NASDAQ OSIR 59 Corp. NASDAQ CRME 59 apoptosis inducer 59 Inc. Amex ILE 59 calcium acetate Nabi HB 59 Nasdaq GTCB 59 PRNewswire FirstCall Halozyme Therapeutics 59 PWRM.OB 59 Webcast Annual Meeting 59 Pirespa 59 BPAX 59 Nasdaq SOMX 59 Clinical Trial Evaluating 59 Provides Guidance 59 BLRX 59 AFX Biopharmaceutical 59 ALIM 59 ABLYNX 59 candidate WF# 59 Brentuximab Vedotin SGN 59 FDA Okays 59 cladribine Cladribine Tablets 59 Extend Collaboration 59 MARKETING AGREEMENTS PRODUCT SOURCE 59 Ophthalmic Drugs Advisory 59 NASDAQ CLSN 59 www.gsk.com 59 Announces Adjournment 59 Inc. NASDAQ ICGN 59 Board Unanimously Rejects 59 IVD Market 59 Endoscopy Laparoscopy 59 WESTMINSTER Colo. BUSINESS WIRE 59 NASDAQ BIOD 58 ImmuCell Corporation 58 Inc. NASDAQ ONTY 58 CancerVax Corporation 58 Significantly Improves 58 PRNewswire FirstCall Sunesis Pharmaceuticals 58 ORADUR ® 58 OTCBB PYTO 58 Amends Agreement 58 Vascular Disrupting Agent 58 Inc. OTCBB VODG 58 GLOBE NEWSWIRE Emisphere Technologies 58 Obtains FDA 58 NASDAQ FLML 58 Inc. Nasdaq PPHM 58 Nasdaq MBRX announced 58 breast cancer pill Tykerb 58 tests miRview TM 58 Nasdaq SPEX 58 NASDAQ DRRX 58 TAXUS Element Paclitaxel Eluting 58 PRNewswire FirstCall Corgentech 58 Receives Delisting Notification 58 Nasdaq SPNC 58 Diagnostic Imaging Devices 58 Receives Positive 58 Nasdaq ALNY 58 candidate XP# 58 proprietary intranasal insulin 58 PRNewswire FirstCall VIVUS 58 SECAUCUS NJ BUSINESS WIRE 58 BioElectronics Announces 58 Kuvan sapropterin dihydrochloride 58 hygienic cleansing 58 Moving Average Crossover Alert 58 Introduces Enhanced 58 Biodel Inc 58 Receives Approvals 58 NASDAQ BMRN 58 AP PhotoExpress Network 58 PPD Declares